Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Viatris Inc VTRS

Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:VTRS)

No current opinion is available.

Bullboard Posts (NDAQ:VTRS)

Viatris 2023 Sustainability Report: Addressing Critical Heal

JUST IN: $VTRS Viatris 2023 Sustainability Report: Addressing Critical Health and Social Needs in IndiaNORTHAMPTON, MA / ACCESSWIRE...
whytestocks - October 15, 2024

Viatris Inc. (NASDAQ:VTRS) &#8211; Bridging the Divide Betwe

http://beyondspx.com/2024/08/01/viatris-inc-nasdaqvtrs-bridging-the-divide-between-generics-and-brands/
MikeTester - August 2, 2024

Lorne Steinberg still lilkes - BNN

TOP PICK Viatris(VTRS-Q) 13/03/2023     It is the cheapest stock in their portfolio...
Possibleidiot01 - March 14, 2023

Though a small drug-maker...

 with a market capitalization of just under $14 billion, this pharmaceutical company is worth a look thanks to its consistent and...
jonahg - August 3, 2022

RE:Paul MacDonALD- BNN - Don't BUY

Lorne and Paul need to go out for a coffee and discuss further.  I have no issue holding and not worrying about this one for many...
Cdnmate23 - February 3, 2022

Paul MacDonALD- BNN - Don't BUY

DON'T BUY Viatris(VTRS-Q) 02/02/2022 at 07:00pm   Includes boring drugs, which provide...
Possibleidiot01 - February 3, 2022